Retropharyngeal Abscess in Children Under 4, or with Significant Abscess Size, Compromised Airway, Sepsis, or Neurovascular Complications
Clinical Scenario
This protocol addresses retropharyngeal abscess presenting with any of the following high-risk features — each representing an indication for immediate, definitive intervention:
Age <4 years
Significant abscess size
Compromised airway
Septicemia / Sepsis
Neurovascular complications
No prior anaphylactic reaction to penicillin
Why These Features Drive Treatment
Age under 4 years and significant abscess size, independent of other findings, are indications for surgical drainage. The presence of a compromised airway, septicemia, or neurovascular complications further indicate the need for immediate surgical treatment regardless of age or abscess size.
Treatment Overview (Partial)
The approach involves immediate surgical drainage of the abscess — with the specific operative route determined by the anatomy and complexity of the case — combined with direct airway management when the airway is at risk. Systemic broad-spectrum antibiotic therapy active against both aerobic and anaerobic pathogens is initiated concurrently, alongside hydration and analgesia.
The complete regimen — antibiotic class selection and sequencing, surgical route criteria, airway management algorithm, and criteria for step-down to oral therapy — is available in the full protocol.
References
- Regardless of age and abscess size, the presence of a compromised airway, septicemia or neurovascular complications suggest immediate surgical treatment.
- SURGICAL DRAINAGE IF: Age <4 years, significant size of abscess, airway compromised, sepsis, complications, no clinical improvement after 48 hours from the initiation of i.v antibiotic therapy.
- For PPA and RPA, an oral approach is suggested when possible. However, PPAs (that are only partially seen in the pharynx) and complicated RPAs must be treated by an external cervical approach as the intraoral approach can be dangerous or would allow full drainage.
- Considering the microbiological characteristics of DNIs, parenteral administration of broad-spectrum antibiotic therapy covering both aerobic and anaerobic pathogens is strongly recommended.
View source ↗